Filing Details
- Accession Number:
- 0001453687-23-000067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-26 18:00:28
- Reporting Period:
- 2023-09-25
- Accepted Time:
- 2023-09-26 18:00:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1453687 | Selecta Biosciences Inc | SELB | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1284500 | G Peter Traber | C/O Selecta Biosciences, Inc. 65 Grove Street Watertown MA 02472 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-09-25 | 705 | $1.06 | 451,826 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
- Includes 6,410 shares of common stock purchased under the Issuer's Employee Stock Purchase Program during the contribution period between September 1, 2022 and February 28, 2023.
Billionaire Hedge Funds
